Tempest Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tempest Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Tempest Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.33M, a 137% increase year-over-year.
  • Tempest Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.07M, a 170% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.55M, a 63.1% increase from 2022.
  • Tempest Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.56M, a 41.3% increase from 2021.
  • Tempest Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.11M, a 144% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.55M +$985K +63.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.56M +$456K +41.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $1.11M +$652K +144% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $453K -$3.86M -89.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $4.32M +$2.89M +203% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $1.43M +$665K +87.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $762K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.